Cero Therapeutics Holdings, Inc.

Ownership Transactions Reported by 18 Insiders

Symbol
CERO, CEROW on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
201 Haskins Way, Suite 230, South San Francisco, CA

Insiders trading volume in the past year

Cero Therapeutics Holdings, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Shami Patel Director $11.2M May 30, 2025
Stuart Sloan 10%+ Owner $2.2M Sep 25, 2024
Brian G. Atwood Director $1M May 30, 2025
YK Bioventures Opportunities GP I, LLC 10%+ Owner $780K -$784K -50.1% Dec 11, 2024
Christopher B. Ehrlich Chairman and CEO, Director $580K May 30, 2025
Douglas Carl Fisher President $483K Feb 14, 2024
Daniel E. Geffken Chief Financial Officer $100K Feb 14, 2024
Phoenix Biotech Sponsor, Llc 10%+ Owner $100K Feb 14, 2024
Laporte Kathleen Director $97.2K May 30, 2025
Caroline M. Loewy Director $58.3K Feb 14, 2024
Barbara Kosacz Director $58.3K Feb 14, 2024
Daniel Corey Chief Technical Officer, Director $26.8K Mar 25, 2024
Robyn Rapaport Director $5K Mar 25, 2024
Kristen Pierce Chief Development Officer May 30, 2025
Lindsey Rolfe Director May 30, 2025
Charles Carter Chief Financial Officer Jun 28, 2024
Michael Byrnes Director May 30, 2025
Andrew Albert Kucharchuk Chief Financial Officer May 30, 2025

Recent Insider Transactions by Companies or Individuals for Cero Therapeutics Holdings, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.